Notice type: 3rd Party Publications
Problem Or Issue:
Important safety information communication from Roche on Osteonecrosis of the jaw in cancer patients in association with bevacizumab, Avastin® and concomitant or previous use of biphosphonates.
Important Safety Information - Avastin (bevacizumab)